JL
Therapeutic Areas
Scipher Medicine Pipeline
| Drug | Indication | Phase |
|---|---|---|
| PrismRA | Rheumatoid Arthritis (predicting anti-TNF response) | Commercial |
| PRoBeNet | Complex Diseases (biomarker discovery) | Discovery |
| Galapagos Collaboration | Inflammatory Bowel Disease | Discovery/Pre-clinical |
| Ionis Partnership | Undisclosed (multi-target) | Discovery |